Get the Stockscreener App
228.41
0.44%
1.20
Overview
News
Price History
Option Chain
Financials
Why BDX Down?
Discussions
Forecast
Stock Split
Dividend History
Becton Dickinson Co stock is traded at $228.41, with a volume of 1.47M.
It is up +0.44% in the last 24 hours and down -1.70% over the past month.
See More
Previous Close:
$227.21
Open:
$229.15
24h Volume:
1.47M
Relative Volume:
0.73
Market Cap:
$68.23B
Revenue:
$20.18B
Net Income/Loss:
$1.71B
P/E Ratio:
38.45
EPS:
5.94
Net Cash Flow:
$3.07B
1W Performance:
-7.83%
1M Performance:
-1.70%
6M Performance:
-1.90%
1Y Performance:
-4.71%
1-Day Range:
$226.55
$229.62
1-Week Range:
$224.34
$251.99
52-Week Range:
$218.75
$251.99
Becton Dickinson Co Stock (BDX) Company Profile
Name
Becton Dickinson Co
Sector
Industry
Phone
(201) 847-6800
Address
ONE BECTON DR, FRANKLIN LAKES
Compare BDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
228.43 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ISRG
Intuitive Surgical Inc
|
585.88 | 209.89B | 8.35B | 2.32B | 1.30B | 6.41 |
|
ALC
Alcon Inc
|
90.29 | 45.33B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
236.33 | 34.84B | 4.93B | 1.25B | 1.38B | 8.47 |
|
WST
West Pharmaceutical Services Inc
|
323.98 | 23.97B | 2.88B | 499.60M | 321.60M | 6.74 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| May-30-24 | Initiated | Goldman | Buy |
| Jul-24-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| May-05-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-12-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-03-23 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-12-22 | Upgrade | Citigroup | Sell → Neutral |
| Jul-11-22 | Downgrade | Citigroup | Neutral → Sell |
| Jun-24-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-18-22 | Resumed | Raymond James | Mkt Perform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-08-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-06-21 | Downgrade | JP Morgan | Overweight → Neutral |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-09-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jun-01-20 | Resumed | Goldman | Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-07-20 | Downgrade | Cowen | Outperform → Market Perform |
| Feb-07-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-07-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Feb-06-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-08-20 | Downgrade | Barclays | Overweight → Equal Weight |
| May-13-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-07-18 | Initiated | Deutsche Bank | Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Jun-21-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-10-18 | Upgrade | Citigroup | Neutral → Buy |
| Jan-19-18 | Resumed | BofA/Merrill | Buy |
| Jan-05-18 | Upgrade | Citigroup | Sell → Neutral |
| Jan-05-18 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Dec-29-17 | Reiterated | Deutsche Bank | Buy |
View All
Becton Dickinson Co Stock (BDX) Latest News
Becton, Dickinson and Company (NYSE:BDX) Q1 2025 Earnings Call Transcript - Insider Monkey
Becton Dickinson & Co (BDX) Q1 2025 Earnings Call Highlights: St - GuruFocus.com
Becton Dickinson & Co (BDX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Becton Dickinson Reports Strong Q1 Financial Results - TipRanks
BD revenue increases 9.8% in Q1 2025; company to separate biosciences, diagnostics biz - Medical Buyer
Becton Dickinson gains amid reports it's evaluating separating life sciences unit - MSN
BD to separate biosciences and diagnostics business - BioWorld Online
Becton Dickinson & Co. stock underperforms Thursday when compared to competitors - MarketWatch
Becton Dickinson to Separate From Bioscience and Diagnostic Solutions Business - MSN
Becton Dickinson’s Strategic Spin-Off and Strong Performance Boost Buy Rating - TipRanks
Buy Rating for Becton Dickinson: Strategic Separation and Strong Financials Drive Positive Outlook - TipRanks
BD announces intent to sell Life Sciences business, beats Street in Q1 - Mass Device
Becton Dickinson Q1 Earnings: Revenue And EPS Beat, Lowers Outlook, Outlines Intent To Separate Biosciences And Diagnostic Solutions Business - Benzinga
BD revenue increases 9.6% to USD 5.2 billion in Q1 2025 - Medical Buyer
Becton Dickinson: Fiscal Q1 Earnings Snapshot - CTPost
Becton, Dickinson And Co. Q1 25 Earnings Conference Call At 8:00 AM ET - Nasdaq
Becton, Dickinson and Company (NYSE:BDX) Stake Lessened by Everett Harris & Co. CA - MarketBeat
Compared to Estimates, Becton Dickinson (BDX) Q1 Earnings: A Look at Key Metrics - MSN
Becton Dickinson to Split from Bioscience and Diagnostic Solutions Arms - TipRanks
Becton, Dickinson and Company Revises Earnings Guidance for the Fiscal Year 2025 - Marketscreener.com
Becton Dickinson & Co Surpasses Q1 Expectations with $3.43 EPS and $5.2 Billion Revenue - GuruFocus.com
Becton Dickinson earnings beat by $0.44, revenue topped estimates - Investing.com Australia
Becton Dickinson & Co Surpasses Q1 Expectations with $3.43 EPS a - GuruFocus.com
Becton looks to separate life sciences unit after upbeat quarterly results -February 05, 2025 at 06:07 pm EST - Marketscreener.com
Becton looks to separate life sciences unit after upbeat quarterly results - Reuters.com
Becton, Dickinson Fiscal Q1 Adjusted EPS, Revenue Increase -February 05, 2025 at 05:23 pm EST - Marketscreener.com
Becton Dickinson to Separate From Bioscience and Diagnostic Solutions Business -February 05, 2025 at 05:10 pm EST - Marketscreener.com
Becton Dickinson and : Presentation Q1 FY25 -February 05, 2025 at 05:08 pm EST - Marketscreener.com
Becton Dickinson Announces Strategic Business Separation Plan - TipRanks
Becton Dickinson: Fiscal Q1 Earnings Snapshot -February 05, 2025 at 04:51 pm EST - Marketscreener.com
Becton Dickinson looks to separate life sciences unit -February 05, 2025 at 04:52 pm EST - Marketscreener.com
Becton Dickinson and Company filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits - Quantisnow
BD Delivers Massive 28% EPS Growth, Unveils Strategic Split to Unlock Shareholder Value - StockTitan
BD (BDX) To Report Earnings Tomorrow: Here Is What To Expect By Stock Story - Investing.com Canada
Mediolanum International Funds Ltd Sells 88,620 Shares of Becton, Dickinson and Company (NYSE:BDX) - MarketBeat
Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors - MarketWatch
Becton, Dickinson and Company (NYSE:BDX) Shares Sold by Kingswood Wealth Advisors LLC - MarketBeat
Becton Dickinson stock rises on activist stake report - MSN
Becton Dickinson looks to divest life sciences unit at $30 billion valuation, source says - MSN
Activist Starboard Value Pushes Becton Dickinson To Divest Life Sciences Unit - Benzinga
Activist investors reportedly push BD to sell Life Sciences biz - Mass Device
Becton Dickinson (NYSE:BDX) Ticks All The Boxes When It Comes To Earnings Growth - Yahoo Finance UK
Becton Dickinson (BDX) Plans Life Sciences Segment Separation - Bloomberg
Starboard Value pushes medical device maker Becton Dickinson to spin off unit - Financial Times
Oregon Pacific Wealth Management LLC Makes New Investment in Becton, Dickinson and Company (NYSE:BDX) - MarketBeat
Becton Dickinson gains amid reports it's evaluating separating life sciences unit (BDX:NYSE) - Seeking Alpha
Becton Dickinson Reportedly Mulling Separation of Life Sciences Division -February 03, 2025 at 07:20 am EST - Marketscreener.com
Starboard Value pushes Becton Dickinson to sell life sciences unit, FT reports -February 03, 2025 at 07:28 am EST - Marketscreener.com
Becton Dickinson stock rises on activist stake report By Investing.com - Investing.com Australia
Becton Dickinson shareholders approve board nominees - MSN
DAVENPORT & Co LLC Sells 16,388 Shares of Becton, Dickinson and Company (NYSE:BDX) - MarketBeat
Becton Dickinson Co Stock (BDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Becton Dickinson Co Stock (BDX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Neal Shana Carol | EVP and Chief People Officer |
Jan 21 '25 |
Sale |
240.00 |
787 |
188,880 |
15,414 |
1.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):